Azamian Bobak R. 13D/13G Filings for Tarsus Pharmaceuticals, Inc. (TARS)

Azamian Bobak R. 13D and 13G filings for Tarsus Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-02-14
4:46 pm
Sale
2021-12-3113GTARSUS PHARMACEUTICALS INC
TARS
Azamian Bobak R.1,426,091
6.800%
-489,204decrease
(-25.54%)
Filing